Efficacy and safety of single-agent zandelisib administered by intermittent dosing in patients with relapsed or refractory (R/R) follicular lymphoma (FL): Final results of the tidal phase 2 study Meeting Abstract
| Authors: | Zelenetz, A. D.; Jurczak, W.; Ribrag, V.; Linton, K. M.; Collins, G. P.; Bishton, M.; López Jiménez, J.; Dholaria, B.; Mengarelli, A.; Phillips, T. J.; Sungala, N. P.; Chan, H.; Musuraca, G.; Sheehy, O.; Yan, J.; Xu, W.; Azoulay, M.; Zinzani, P. L. |
| Abstract Title: | Efficacy and safety of single-agent zandelisib administered by intermittent dosing in patients with relapsed or refractory (R/R) follicular lymphoma (FL): Final results of the tidal phase 2 study |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 3595 |
| End Page: | 3597 |
| Language: | English |
| ACCESSION: | WOS:000893223203281 |
| DOI: | 10.1182/blood-2022-165409 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
